Leaflet COGNOMEM 5mg 5mg / dose eliberata oral solution
Memantine is a medication used to treat moderate to severe dementia associated with Alzheimer’s disease. It works by blocking NMDA (N-methyl-D-aspartate) receptors in the brain, reducing the excessive effects of glutamate, a neurotransmitter that, in high amounts, can contribute to nerve cell damage.
Memantine helps improve cognitive function, memory, and the ability to perform daily activities, but it does not cure Alzheimer’s disease. It is usually administered in tablet or oral solution form, with the dose gradually adjusted to minimize side effects.
Side effects may include dizziness, headaches, constipation, drowsiness, or confusion. In rare cases, hallucinations or high blood pressure may occur. It is important to take the medication as prescribed by a doctor, with regular monitoring of the patient’s condition.
Memantine helps improve cognitive function, memory, and the ability to perform daily activities, but it does not cure Alzheimer’s disease. It is usually administered in tablet or oral solution form, with the dose gradually adjusted to minimize side effects.
Side effects may include dizziness, headaches, constipation, drowsiness, or confusion. In rare cases, hallucinations or high blood pressure may occur. It is important to take the medication as prescribed by a doctor, with regular monitoring of the patient’s condition.
General data about COGNOMEM 5mg 5mg / dose eliberata
- Substance:
- memantine
- Date of latest medicines list:
- 01-07-2015
- Product code:
- W60438001
- Concentration:
- 5mg / dose eliberata
- Pharmaceutical form:
- oral solution
- Quantity:
- 1
- Product type:
- Generic medicine
- Prescription status:
- P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Pharmaceutical forms available for memantine
Concentrations available for memantine
- 10mg
- 10mg/g
- 10mg/ml
- 15mg
- 20mg
- 5mg
- 5mg/10mg/15mg/20mg
- 5mg/dose
- 5mg/dose eliberata